nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A controlled trial comparing budesonide with mesalazine for the treatment of active Crohn disease
|
Copaci, I. |
|
2000 |
32 |
S1 |
p. A23- 1 p. |
artikel |
2 |
Activin a modulates intestinal epithelial cell function in vitro
|
Jung, S. |
|
2000 |
32 |
S1 |
p. A19- 1 p. |
artikel |
3 |
Additional evidence for an inflammatory bowel disease (IBD) locus on 14q11–12
|
Vermeire, S. |
|
2000 |
32 |
S1 |
p. A49- 1 p. |
artikel |
4 |
Anastomotic configuration and recurrence of ileocolonic Crohn's disease
|
Alessandroni, L. |
|
2000 |
32 |
S1 |
p. A36- 1 p. |
artikel |
5 |
Ankylosing spondylitis in ulcerative colitis
|
Krstic, M. |
|
2000 |
32 |
S1 |
p. A49- 1 p. |
artikel |
6 |
A novel role for the neuropeptide neurotensin in chronic colitis
|
Cataldi, F. |
|
2000 |
32 |
S1 |
p. A34- 1 p. |
artikel |
7 |
Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes apoptosis in experimental murine colitis
|
Ito, H. |
|
2000 |
32 |
S1 |
p. A28- 1 p. |
artikel |
8 |
Anti-P53 serum antibodies: A new strategy for improving colorectal cancer surveillance in ulcerative colitis
|
Riegler, G. |
|
2000 |
32 |
S1 |
p. A12- 1 p. |
artikel |
9 |
Anti-saccharomyces cerevisiae mannan (ASCA) antibodies in inflamatory bowel disease (IBD)
|
Annese, V. |
|
2000 |
32 |
S1 |
p. A6- 1 p. |
artikel |
10 |
Apoptosis in colon of rat with induced colitis
|
Della Valle, N. |
|
2000 |
32 |
S1 |
p. A41- 1 p. |
artikel |
11 |
A rare association between inflammatory bowel disease (IBD), coeliac disease, membranous glomerulonephritis and leg venous thrombosis associated to heterozygosis for V Leiden factor
|
Casella, Giovanni |
|
2000 |
32 |
S1 |
p. A44- 1 p. |
artikel |
12 |
ASCA detection in an Italian IBD population: Preliminary results
|
Daperno, M. |
|
2000 |
32 |
S1 |
p. A14- 1 p. |
artikel |
13 |
Author index
|
|
|
2000 |
32 |
S1 |
p. A53-A57 nvt p. |
artikel |
14 |
Azathioprine metabolite levels: A therapeutic index of clinical efficacy in IBD
|
Cuffari, C. |
|
2000 |
32 |
S1 |
p. A52- 1 p. |
artikel |
15 |
Bacteria in pouch tissue
|
Helwig, U. |
|
2000 |
32 |
S1 |
p. A38- 1 p. |
artikel |
16 |
B2-microglobulin plasma level in remission as a prognostic test of the severity of relapse in ulcerative colitis
|
Mishurovskaja, T. |
|
2000 |
32 |
S1 |
p. A25- 1 p. |
artikel |
17 |
Bowel ultrsonography in detecting bowel stenosis in inflammatory bowel diseases
|
Mijalkovic, N. |
|
2000 |
32 |
S1 |
p. A46- 1 p. |
artikel |
18 |
Budesonide in the treatment of Crohn's disease. A meta-analysis
|
Papi, C. |
|
2000 |
32 |
S1 |
p. A11- 1 p. |
artikel |
19 |
Budesonide is superior to mesalazine in maintaining disease remission for patients with steroid-dependent Crohn's disease
|
Mantzaris, G.J. |
|
2000 |
32 |
S1 |
p. A29- 1 p. |
artikel |
20 |
Cancer in the anal canal after handsewn ileoanal anastomosis, report of a case
|
Laureti, S. |
|
2000 |
32 |
S1 |
p. A38- 1 p. |
artikel |
21 |
Carnitine levels in colon, muscle and serum of rats with experimental colitis
|
Cosenza, V. |
|
2000 |
32 |
S1 |
p. A9- 1 p. |
artikel |
22 |
CD2-mediated activation of stat: Transactivation of the IFN-γ intronic stat cis-element is unique for LPMC and independent of IL-12
|
Gonsky, R. |
|
2000 |
32 |
S1 |
p. A27- 1 p. |
artikel |
23 |
Changing patterns in pediatric-onset Crohn's disease: A 30 year epidemiologic study
|
Critch, J.N. |
|
2000 |
32 |
S1 |
p. A21- 1 p. |
artikel |
24 |
Characterization of single nucleotide polymorphism (SNP) haplotypes of IL4 receptor α gene in inflammatory bowel disease
|
Zhang, W.J. |
|
2000 |
32 |
S1 |
p. A21- 1 p. |
artikel |
25 |
Chemokine expression in pouchitis
|
Lammers, K.M. |
|
2000 |
32 |
S1 |
p. A39- 1 p. |
artikel |
26 |
Cholestyramine's ability to bind intestinal bacterial products: potential role in IBD
|
Christian, Aimee E. |
|
2000 |
32 |
S1 |
p. A50- 1 p. |
artikel |
27 |
Clinical and endoscopic characteristics of indeterminate colitis as predictive signs of the definitive diagnosis
|
Pica, R. |
|
2000 |
32 |
S1 |
p. A14- 1 p. |
artikel |
28 |
Clinical course of familial and sporadic cases of Crohn's disease
|
Orlando, A. |
|
2000 |
32 |
S1 |
p. A13- 1 p. |
artikel |
29 |
Colitis mimicking Crohn's disease in patient with rheumatoid arthritis
|
Pirrelli, M. |
|
2000 |
32 |
S1 |
p. A13- 1 p. |
artikel |
30 |
Comparison of oral versus combination mesalazine therapy in active ulcerative colitis: A duble-blind, double-dummy, randomized, multi-center Italian study
|
Vecchi, M. |
|
2000 |
32 |
S1 |
p. A36- 1 p. |
artikel |
31 |
Complementary therapy in IBD patients: Who uses it and why?
|
Rampton, D.S. |
|
2000 |
32 |
S1 |
p. A33- 1 p. |
artikel |
32 |
Connective tissue changes in ileal Crohn's disease; relationship to disease phenotype and ulcer associated cell lineage
|
Borley, N.R. |
|
2000 |
32 |
S1 |
p. A22- 1 p. |
artikel |
33 |
Correlation between disease knowledge and quality of life in IBD patients
|
Niemer, Sally |
|
2000 |
32 |
S1 |
p. A23- 1 p. |
artikel |
34 |
Correlations between inflammatory bowel disease and colonic cancer in Romania
|
Bataga, S. |
|
2000 |
32 |
S1 |
p. A49- 1 p. |
artikel |
35 |
Crohn's disease of the upper intestinal tract
|
Luetke, A. |
|
2000 |
32 |
S1 |
p. A18- 1 p. |
artikel |
36 |
Diagnosis of fistulas in Crohn's disease with power doppler sonography (PDUS)
|
Maconi, G. |
|
2000 |
32 |
S1 |
p. A37- 1 p. |
artikel |
37 |
Different strictureplasty options to avoid resections in complicated Crohn's disease
|
Danelli, P.G. |
|
2000 |
32 |
S1 |
p. A33- 1 p. |
artikel |
38 |
Discordant sibling pair linkage analysis provides further support for the chromosome 12 inflammatory bowel disease susceptibility locus
|
van Heel, D.A. |
|
2000 |
32 |
S1 |
p. A19- 1 p. |
artikel |
39 |
Distinct cytokine patterns differentiate early vs. late colitis in IL-10-deficient mice
|
Spencer, D.M. |
|
2000 |
32 |
S1 |
p. A21- 1 p. |
artikel |
40 |
Distinctive patterns of inflammatory response in microscopic colitis compared with resolving Campylobacter enteritis
|
Jenkins, D. |
|
2000 |
32 |
S1 |
p. A31- 1 p. |
artikel |
41 |
DNA aneuploidy in long-standing ulcerative colitis
|
D'Albasio, G. |
|
2000 |
32 |
S1 |
p. A7- 1 p. |
artikel |
42 |
Does close rectal dissection for proctectomy in inflammatory bowel disease protect against impotence?
|
Lindsey, I. |
|
2000 |
32 |
S1 |
p. A19- 1 p. |
artikel |
43 |
Does the full remission of ulcerative colitis exist?
|
Belousova, E. |
|
2000 |
32 |
S1 |
p. A27- 1 p. |
artikel |
44 |
E-cadherin expression in Crohn's disease
|
Di Sabatino, A. |
|
2000 |
32 |
S1 |
p. A39- 1 p. |
artikel |
45 |
Echodoppler of the inferior mesenteric artery in monitoring response to therapy in patients suffering from acute ulceratibe colitis
|
Giannetti, A. |
|
2000 |
32 |
S1 |
p. A43- 1 p. |
artikel |
46 |
Effectiveness evaluation of 3 probiotics from different strains of lactobacilli under clinical conditions
|
Lizko, N. |
|
2000 |
32 |
S1 |
p. A24- 1 p. |
artikel |
47 |
Epidermal growth factor receptor is associated with evidence of smooth muscle proliferation in Crohn's disease ulcers
|
Borley, N.R. |
|
2000 |
32 |
S1 |
p. A22- 1 p. |
artikel |
48 |
Epithelial and lymphocyte apoptosis in Crohn's disease (CD)
|
Di Sabatino, A. |
|
2000 |
32 |
S1 |
p. A42- 1 p. |
artikel |
49 |
Epithelial proliferation and ras p21 oncoprotein in the rectum of patients with ulcerative colitis
|
Ierardi, E. |
|
2000 |
32 |
S1 |
p. A5- 1 p. |
artikel |
50 |
Epithelial regeneration is dysregulated in SAMP1/YIT mice, a spontaneous model of Crohn's disease
|
Tustison, K. |
|
2000 |
32 |
S1 |
p. A15- 1 p. |
artikel |
51 |
ERBB-1 expression in experimental model of inflammatory bowel disease in rats
|
Trzcinski, R. |
|
2000 |
32 |
S1 |
p. A51- 1 p. |
artikel |
52 |
Etanercept (TNF receptor fusion protein, enbrel®) is effective and well tolerated in active refractory Crohn's disease: Results of a single center pilot trial
|
D'Haens, G. |
|
2000 |
32 |
S1 |
p. A42- 1 p. |
artikel |
53 |
Evaluation of the tumor necrosis factor (TNF) family of inhibitors in the dextran sulfate model of mouse colitis
|
Murthy, S. |
|
2000 |
32 |
S1 |
p. A20- 1 p. |
artikel |
54 |
Evolution of microscopic features of ulcerative colitis during follow-up
|
Ambu, R. |
|
2000 |
32 |
S1 |
p. A18- 1 p. |
artikel |
55 |
Experimental colitis increases small bowel permeability to sugar probes in the Wistar-Kyoto (WKY) rat
|
Giofré, M.R. |
|
2000 |
32 |
S1 |
p. A10- 1 p. |
artikel |
56 |
Expression of B7 costimulatory molecules in experimental inflammatory bowel disease
|
Howarth, G.S. |
|
2000 |
32 |
S1 |
p. A30- 1 p. |
artikel |
57 |
Extracolonic manifestation of the ulcerative colitis: pyoderma gangrenosum
|
Paszkowski, J. |
|
2000 |
32 |
S1 |
p. A16- 1 p. |
artikel |
58 |
Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area
|
Rosselli, M. |
|
2000 |
32 |
S1 |
p. A10- 1 p. |
artikel |
59 |
Faecal sIgA in the evaluation of integrity of mucosa systems of defence
|
Vikha, G. |
|
2000 |
32 |
S1 |
p. A45- 1 p. |
artikel |
60 |
Family history of colorectal cancer is a risk factor for early-onset colorectal cancer in inflammatory bowel disease
|
Askling, J. |
|
2000 |
32 |
S1 |
p. A24- 1 p. |
artikel |
61 |
Fibrosing colonopathy associated with mesalazine treatment in adult patient
|
Sambataro, A. |
|
2000 |
32 |
S1 |
p. A43- 1 p. |
artikel |
62 |
Focally enhanced gastritis could be patognomonic for Crohn's disease
|
Lecis, P.E. |
|
2000 |
32 |
S1 |
p. A42- 1 p. |
artikel |
63 |
Gallstone and Crohn's disease. Results from a large cohort
|
Losco, A. |
|
2000 |
32 |
S1 |
p. A42- 1 p. |
artikel |
64 |
Genetic and inflammatory bowel disease(IBD): is there a relationship between polymorphisms of hMLH1 gene and different subtype of ulcerative colitis (UC)?
|
Tarantino, O. |
|
2000 |
32 |
S1 |
p. A15- 1 p. |
artikel |
65 |
Gut pH and transit time in ulcerative colitis appear sufficient for complete dissolution of pH-dependent 5-ASA-containing capsules
|
Nugent, S.G. |
|
2000 |
32 |
S1 |
p. A45- 1 p. |
artikel |
66 |
Healing of perianal fistulae by local injection of antibody to TNFα Simon Lichtiger M.D. Mount Sinai Medical Center New York
|
|
|
2000 |
32 |
S1 |
p. A5- 1 p. |
artikel |
67 |
Helminthic parasite exposure protects mice from colitis
|
Elliott, D. |
|
2000 |
32 |
S1 |
p. A26- 1 p. |
artikel |
68 |
Heme oxygenase-1 (HO-1) induction in human intestinal epithelial cells by sulphasalazine, 5-aminosalicyclic acid and bismuth citrate: A novel potential therapeutic mechanism
|
Cavicchi, M. |
|
2000 |
32 |
S1 |
p. A23- 1 p. |
artikel |
69 |
Herbal therapies used by patients for inflammatory bowel disease are antioxidant in vitro
|
Langmead, L. |
|
2000 |
32 |
S1 |
p. A48- 1 p. |
artikel |
70 |
High-density genome scan in Crohn's disease shows linkage to chromosome 14Q and linkage and association with chromosome 3P
|
Duerr, R.H. |
|
2000 |
32 |
S1 |
p. A27- 1 p. |
artikel |
71 |
Highly concentrated probiotics prevent pouchitis onset
|
Amadini, C. |
|
2000 |
32 |
S1 |
p. A12- 1 p. |
artikel |
72 |
HLA-dependent and HLA-independent forms of ulcerative colitis (UC) in Russia
|
Morozova, N. |
|
2000 |
32 |
S1 |
p. A27- 1 p. |
artikel |
73 |
HLA-DRB1 gene may be the specific genetic marker in patients with distal ulcerative colitis
|
Khalif, I.L. |
|
2000 |
32 |
S1 |
p. A35- 1 p. |
artikel |
74 |
Identification of two novel susceptibility loci in a Canadian inflammatory bowel disease population
|
Rioux, J.D. |
|
2000 |
32 |
S1 |
p. A20- 1 p. |
artikel |
75 |
Ileal adenocarcinoma: Intraoperatory evidence at first diagnosis of Crohn's disease
|
Demarchi, B. |
|
2000 |
32 |
S1 |
p. A7- 1 p. |
artikel |
76 |
Ileo-colonic inflammation in spondyloarthropathies (SpA) of childhood
|
Franco, M.T. |
|
2000 |
32 |
S1 |
p. A40- 1 p. |
artikel |
77 |
Immunohystochemical study of nitric oxide synthase's (NOS) activity in IBD colonic mucosa
|
Palatka, K. |
|
2000 |
32 |
S1 |
p. A20- 1 p. |
artikel |
78 |
Immunostimulatory DNA sequences ameliorate experimental colitis in mice and rats
|
Rachmilewitz, D. |
|
2000 |
32 |
S1 |
p. A31- 1 p. |
artikel |
79 |
Impact of inflammatory bowel disease on patient genital life
|
Fekih, M. |
|
2000 |
32 |
S1 |
p. A50- 1 p. |
artikel |
80 |
Inactive tissue transglutaminase in rats with experimental colitis
|
D'Argenio, G. |
|
2000 |
32 |
S1 |
p. A8- 1 p. |
artikel |
81 |
Incidence and treatment for intestinal obstruction after ileoanal anastomosis
|
Ugolini, F. |
|
2000 |
32 |
S1 |
p. A38- 1 p. |
artikel |
82 |
Incidence and treatment for late perianal fistula after ileoanal anastomosis
|
Laureti, S. |
|
2000 |
32 |
S1 |
p. A15- 1 p. |
artikel |
83 |
Indeterminate colitis and other relative controindications to restorative proctocolectomy: Immediate and long-term results
|
Montesani, C. |
|
2000 |
32 |
S1 |
p. A52- 1 p. |
artikel |
84 |
Indeterminate colitis (IC) in IBD patients in Moscow Region (Russia)
|
Zlatkina, A.R. |
|
2000 |
32 |
S1 |
p. A47- 1 p. |
artikel |
85 |
Inflammation-induced impairment of cholinergic nerve function is mediated by macrophage-colony stimulating factor-dependent macrophages
|
Galeazzi, F. |
|
2000 |
32 |
S1 |
p. A32- 1 p. |
artikel |
86 |
Inflammatory bowel disease (IBD) in children five years of age and younger; a diagnostic dilemma
|
Mamula, Petar |
|
2000 |
32 |
S1 |
p. A51- 1 p. |
artikel |
87 |
Inflammatory bowel diseeses are associated with the DNA repair gene MLH
|
Annese, V. |
|
2000 |
32 |
S1 |
p. A6- 1 p. |
artikel |
88 |
Infliximab binds human monocytes but not mucosal T cells in vitro: No direct anti-T cell mechanism of action
|
Kugathasan, S. |
|
2000 |
32 |
S1 |
p. A45- 1 p. |
artikel |
89 |
Infliximab therapy in 100 Crohn's disease patients: Clinical efficacy and adverse events
|
Farrell, R.J. |
|
2000 |
32 |
S1 |
p. A16- 1 p. |
artikel |
90 |
Inherited thrombophilia in inflammatory bowel disease
|
Papa, A. |
|
2000 |
32 |
S1 |
p. A36- 1 p. |
artikel |
91 |
Inhibition of inducible nitric oxide synthase (iNOS) by bismuth preparations and sulphasalasine in human intestinal epithelial cells
|
Whittle, B.J.R. |
|
2000 |
32 |
S1 |
p. A23- 1 p. |
artikel |
92 |
Interleukin-18 as a marker for disease specificity and severity in patients with IBD
|
Makipour, K. |
|
2000 |
32 |
S1 |
p. A25- 1 p. |
artikel |
93 |
Interleukin-12 receptor β2, a crucial component in the IL-12 TH1 response, is up-regulated in Crohn's disease
|
Parrello, T. |
|
2000 |
32 |
S1 |
p. A52- 1 p. |
artikel |
94 |
Kinetics of ASCA: A time-related study in a Belgian CD population
|
Joossens, S. |
|
2000 |
32 |
S1 |
p. A46- 1 p. |
artikel |
95 |
Lack of activation of plasma contact system in Crohn's disease: A possible role of increased C1-inhibitor levels
|
Devani, M. |
|
2000 |
32 |
S1 |
p. A37- 1 p. |
artikel |
96 |
Lactobacterine in prevention of the acute intestinal infections of flying personnel
|
Belakovsky, M. |
|
2000 |
32 |
S1 |
p. A24- 1 p. |
artikel |
97 |
Laparoscopically-assisted ileocolonic resection for Crohn's disease
|
Alessandroni, L. |
|
2000 |
32 |
S1 |
p. A36- 1 p. |
artikel |
98 |
“Late onset” idiopathic pancreatitis in childre with ulcerative colitis : case report
|
Romano, C. |
|
2000 |
32 |
S1 |
p. A44- 1 p. |
artikel |
99 |
Linkage to IBD1 locus does not identify specific clinical phenotypes in familial IBD patients
|
Annese, V. |
|
2000 |
32 |
S1 |
p. A6- 1 p. |
artikel |
100 |
Lipid profile in patients with Crohn's disease: Relationship with disease localisation and metabolic variables
|
Capristo, E. |
|
2000 |
32 |
S1 |
p. A39- 1 p. |
artikel |
101 |
Long-term impact of Crohn's disease (CD) pharmacotherapy: Treat registry baseline results
|
Sandborn, W. |
|
2000 |
32 |
S1 |
p. A40- 1 p. |
artikel |
102 |
Low dosage of intravenous cyclosporine in the treatment of severe ulcerative colitis
|
Rosselli, M. |
|
2000 |
32 |
S1 |
p. A9- 1 p. |
artikel |
103 |
Macrophages do not contribute to dextran-sulfate induced colitis
|
Ford, D. |
|
2000 |
32 |
S1 |
p. A32- 1 p. |
artikel |
104 |
Maintenance of remission of ulcerative colitis (UC): Mesalamine, dietary fiber, S. Boulardi
|
Copaci, I. |
|
2000 |
32 |
S1 |
p. A24- 1 p. |
artikel |
105 |
Markovian features in longstanding ulcerative colitis
|
Armentano, R. |
|
2000 |
32 |
S1 |
p. A13- 1 p. |
artikel |
106 |
May a failure of the therapy with anti-TNFα (infliximab) reveal a misdiagnosis of Crohn's disease?
|
Ierardi, E. |
|
2000 |
32 |
S1 |
p. A5- 1 p. |
artikel |
107 |
Meeting calendar
|
|
|
2000 |
32 |
S1 |
p. A1-A4 nvt p. |
artikel |
108 |
Metronidazole treatment of bacterial overgrowth in patients with Crohn's disease: Assessment by hydrogen/methane lactulose breath test
|
Castiglione, G. |
|
2000 |
32 |
S1 |
p. A51- 1 p. |
artikel |
109 |
Modulation in the expression of intestinal MUC3 mucin by non-pathogenic probiotic microbes
|
Mack, D.R. |
|
2000 |
32 |
S1 |
p. A29- 1 p. |
artikel |
110 |
Mucosal integrity and apoptosis: Efficient and rapid execution of programmed cell death in primary human intestinal epithelial cells which die of apoptosis as they reach the intestinal lumen
|
Grossmann, J. |
|
2000 |
32 |
S1 |
p. A16- 1 p. |
artikel |
111 |
NK-1R and NK-2R gene and protein expression in Crohn's disease (CD) and ulcerative colitis (UC)
|
Renzi, D. |
|
2000 |
32 |
S1 |
p. A8- 1 p. |
artikel |
112 |
N-L-glutamyl-UDCA as prodrug for colon-specific drug delivery
|
Clerici, Carlo |
|
2000 |
32 |
S1 |
p. A11- 1 p. |
artikel |
113 |
Nominal evidence for linkage to chromosome 3p21 in Finnish IBD families: No association with chemokine receptor, CCR5
|
Paavola, P. |
|
2000 |
32 |
S1 |
p. A14- 1 p. |
artikel |
114 |
Normalization of bowel wall after strictureplasty and miniresection for complicated Crohn's disease
|
Sampietro, G.M. |
|
2000 |
32 |
S1 |
p. A34- 1 p. |
artikel |
115 |
Open labeled pilot study of thalidomide (THAL) as a novel therapy for medically resistant ulcerative colitis (UC)
|
Kam, L.Y. |
|
2000 |
32 |
S1 |
p. A48- 1 p. |
artikel |
116 |
Oral 5-ASA is protective against proximal extention of the mucosomal inflammation in ulcerative proctitis
|
Pica, R. |
|
2000 |
32 |
S1 |
p. A41- 1 p. |
artikel |
117 |
Osteopenia is frequent in children with Crohn's disease at diagnosis
|
Griffiths, A.M. |
|
2000 |
32 |
S1 |
p. A17- 1 p. |
artikel |
118 |
Our experience in restorative proctocolectomy and s-pouch procedure for ulcerative colitis
|
Montecamozzo, G. |
|
2000 |
32 |
S1 |
p. A34- 1 p. |
artikel |
119 |
Oxidant stress has specific and potent effects on the expression of collagen and collagenase by human intestinal smooth muscle (HISM) cells
|
Graham, M. |
|
2000 |
32 |
S1 |
p. A22- 1 p. |
artikel |
120 |
Oxidative DNA damage in ulcerative colitis
|
D'Incà, R. |
|
2000 |
32 |
S1 |
p. A12- 1 p. |
artikel |
121 |
Paediatric inflammatory bowel disease in Tuscany, Italy
|
Lionetti, P. |
|
2000 |
32 |
S1 |
p. A13- 1 p. |
artikel |
122 |
Perinuclear anti-neutrophil cytoplasmatic antibodies (p-ANCA) and anti-saccharomyces cerevisiae antibodies (ASCA) assays in the diagnosis of inflammatory bowel disease (IBD)
|
Vecchi, M. |
|
2000 |
32 |
S1 |
p. A37- 1 p. |
artikel |
123 |
Persistent need for surgical management of Crohn's fistuli after remicade treatment
|
Koltun, W.A. |
|
2000 |
32 |
S1 |
p. A43- 1 p. |
artikel |
124 |
Population differences in allelic associations of the interleukin-1 gene cluster (IL-1B, IL-1 Re and IL-1 Ra), and plasma concentrations of IL-1B and IL-1 Ra in South African patients with inflammatory bowel diseases (IBD) and control individuals
|
Gaillard, M.C. |
|
2000 |
32 |
S1 |
p. A50- 1 p. |
artikel |
125 |
Pouch surgery: Outcome in patients with ulcerative colitis
|
Selvaggi, F. |
|
2000 |
32 |
S1 |
p. A9- 1 p. |
artikel |
126 |
Prediction of relapse after treatment with infliximab in patients with Crohn's disease by increased peripheral production of TNF-α and mucosal levels of activated NFκB
|
Nikolaus, S. |
|
2000 |
32 |
S1 |
p. A21- 1 p. |
artikel |
127 |
Predictive factors of recurrence in Crohn's disease
|
Fekih, M. |
|
2000 |
32 |
S1 |
p. A28- 1 p. |
artikel |
128 |
Presentation of colorectal cancer in patients with ulcerative colitis: a GISC-GSMII multicenter investigation
|
Riegler, G. |
|
2000 |
32 |
S1 |
p. A10- 1 p. |
artikel |
129 |
Prevalence, clinical, laboratory and immunogenetic aspects of articular manifestations in inflammatory bowel disease (IBD)
|
Ferronato, A. |
|
2000 |
32 |
S1 |
p. A43- 1 p. |
artikel |
130 |
Prevalence of cytomegalovirus (CMV) infection in severe refractory IBD colitis
|
Pietrosi, G. |
|
2000 |
32 |
S1 |
p. A9- 1 p. |
artikel |
131 |
Prevalence of Helicobacter pylori infection in patients at diagnosis of inflammatory bowel disease (IBD)
|
Pellicano, R. |
|
2000 |
32 |
S1 |
p. A7- 1 p. |
artikel |
132 |
Prevention of pancreatitis by weekly amylase assay in patients with Crohn's disease treated with azathioprine
|
Castiglione, F. |
|
2000 |
32 |
S1 |
p. A5- 1 p. |
artikel |
133 |
Primary sclerosing cholangitis at the patients operated due to ulcerative colitis
|
Pyda, P. |
|
2000 |
32 |
S1 |
p. A16- 1 p. |
artikel |
134 |
Prognostic indicators for complications after surgery in Crohn's disease
|
Bresso, F. |
|
2000 |
32 |
S1 |
p. A7- 1 p. |
artikel |
135 |
Prophylaxis of postoperative recurrence of Crohn's disease: Combination of antibiotic and probiotic versus mesalamine
|
Rizzello, F. |
|
2000 |
32 |
S1 |
p. A37- 1 p. |
artikel |
136 |
Quality of life evaluation in patients with ulcerative colitis in a randomized clinical trial: Responsiveness and validity of a disease-specific questionnaire
|
Saibeni, S. |
|
2000 |
32 |
S1 |
p. A35- 1 p. |
artikel |
137 |
Quote-IBD: The patients' opinion is necessary in quality of care
|
Russel, M. |
|
2000 |
32 |
S1 |
p. A29- 1 p. |
artikel |
138 |
Randomized, controlled trial to compare the J and W pouch configurations for ulcerative colitis in the maturation period
|
Selvaggi, F. |
|
2000 |
32 |
S1 |
p. A10- 1 p. |
artikel |
139 |
Rapid and prolonged closure of Crohn's disease fistulas with intensified immunosuppressive therapy
|
Engelhardt, E. |
|
2000 |
32 |
S1 |
p. A28- 1 p. |
artikel |
140 |
Reduced plasma antioxidants levels and increased oxidative DNA damage in inflammatory bowel diseases
|
Bortolan, S. |
|
2000 |
32 |
S1 |
p. A12- 1 p. |
artikel |
141 |
Regional expression of thymus expressed chemokine (TECK) and its receptor CCR9 in the small bowel: Evidence for enhanced recirculation of CCR9+ lymphocytes in small bowel Crohn's disease
|
Papadakis, K.A. |
|
2000 |
32 |
S1 |
p. A44- 1 p. |
artikel |
142 |
Regulation of CD4+ T cell functions by lactobacilli
|
von der Weid, T. |
|
2000 |
32 |
S1 |
p. A40- 1 p. |
artikel |
143 |
Rehydration measures in patients with a high flow ileostomy or severe diarrhoea — A new promising concept
|
Leif, Hultén |
|
2000 |
32 |
S1 |
p. A30- 1 p. |
artikel |
144 |
Relationship between clinical, endoscopy and histology activity index in patients with complicated Crohn's disease
|
Pavlovic, A. |
|
2000 |
32 |
S1 |
p. A46- 1 p. |
artikel |
145 |
Resiliency of a model human intestinal epithelium to FAS-mediated apoptotic injury
|
Abreu, M.T. |
|
2000 |
32 |
S1 |
p. A19- 1 p. |
artikel |
146 |
Response to azathioprine therapy in Crohn's disease: A logistic regression model
|
Demarchi, B. |
|
2000 |
32 |
S1 |
p. A8- 1 p. |
artikel |
147 |
Role of inducible nitric oxide synthase in a spontaneously developing chronic colitis in interleukin-10 deficient mice
|
McCafferty, D.-M. |
|
2000 |
32 |
S1 |
p. A47- 1 p. |
artikel |
148 |
Role of leptin and TNF-α in energy metabolism regulation in patients with inflammatory bowel disease
|
Capristo, E. |
|
2000 |
32 |
S1 |
p. A39- 1 p. |
artikel |
149 |
Role of occludin in inflammation-induced permeability alterations of the terminal ileum in the rat
|
Fries, W. |
|
2000 |
32 |
S1 |
p. A11- 1 p. |
artikel |
150 |
Role of Saccharomyces boulardii in the prevention of clinical relapses of Crohn's disease
|
Guslandi, M. |
|
2000 |
32 |
S1 |
p. A44- 1 p. |
artikel |
151 |
Role of the CD40 in the inflammatory bowel diseases (IBD) : Histochemical analysis and clinical correlation
|
Polese, L. |
|
2000 |
32 |
S1 |
p. A41- 1 p. |
artikel |
152 |
RXR and PPARγ nuclear receptors exert a synergistic anti-inflammatory effect. Potential role in ulcerative colitis (UC)
|
Desreumaux, P. |
|
2000 |
32 |
S1 |
p. A32- 1 p. |
artikel |
153 |
Serum chondrex (YLK-40) in patients with arthritis associated with inflammatory bowel disease (IBD)
|
Ferronato, A. |
|
2000 |
32 |
S1 |
p. A11- 1 p. |
artikel |
154 |
Short-term efficacy of chimeric monoclonal antibody cA2 to tumor necrosis factor α for refractory, fistulizing Crohn's disease
|
Bollani, S. |
|
2000 |
32 |
S1 |
p. A34- 1 p. |
artikel |
155 |
Side to side isoperistaltic strictureplasty in Crohn disease: Report of two cases
|
Sommariva, A. |
|
2000 |
32 |
S1 |
p. A14- 1 p. |
artikel |
156 |
Small bowel permeability (using lactulose/mannitol and lactulose/xylose tests) in patients with Crohn's disease and ulcerative proctocolitis
|
Kohout, P. |
|
2000 |
32 |
S1 |
p. A40- 1 p. |
artikel |
157 |
Small intestinal luminal pH in Crohn's disease: Implications for release of antiinflammatory drugs from pH-dependent capsules
|
Nugent, S.G. |
|
2000 |
32 |
S1 |
p. A47- 1 p. |
artikel |
158 |
Smoking and inflammatory bowel deseases (IBD)
|
Guglielmi, V. |
|
2000 |
32 |
S1 |
p. A51- 1 p. |
artikel |
159 |
Sodium glucose co-transporter activity and gene expression in the human ileum in Crohn's disease
|
Wild, G.E. |
|
2000 |
32 |
S1 |
p. A25- 1 p. |
artikel |
160 |
Stapled end-to-side vs sutured side-to-side anastomosis in Crohn's disease
|
Scarpa, M. |
|
2000 |
32 |
S1 |
p. A41- 1 p. |
artikel |
161 |
Surgical strategy, complications and long term prognosis of conservative surgery in Crohn's disease
|
Cristaldi, M. |
|
2000 |
32 |
S1 |
p. A35- 1 p. |
artikel |
162 |
Survival and multiplication of adherent-invasive E. coli strains isolated from patients with Crohn's disease (CD) in the J774 murine macrophage-like cell line
|
Glasser, A.-L. |
|
2000 |
32 |
S1 |
p. A22- 1 p. |
artikel |
163 |
Tarnsabdominal bowel sonography in gastroduodenal Crohn's disease
|
Grbovic, A. |
|
2000 |
32 |
S1 |
p. A45- 1 p. |
artikel |
164 |
TGF-β and IL-10 preserve macromolecular transport during IL-4 induced increased permeability in T84 monolayers
|
Di Leo, V. |
|
2000 |
32 |
S1 |
p. A33- 1 p. |
artikel |
165 |
The assessment of nutritional state of surgical patients with IBD and its clinical importance
|
Skowroñska-Piekarska, U. |
|
2000 |
32 |
S1 |
p. A17- 1 p. |
artikel |
166 |
The blood vessels changes at the patients with ulcerative colitis—the cause or the result of the disease?
|
Banasiewicz, T. |
|
2000 |
32 |
S1 |
p. A17- 1 p. |
artikel |
167 |
The CCR5-Δ32 gene mutation is not associated with inflammatory bowel disease
|
Craggs, A. |
|
2000 |
32 |
S1 |
p. A29- 1 p. |
artikel |
168 |
The determination of P-ANCA and ASCA could be useful in differentiating Crohn's disease from ulcerative colitis
|
Lecis, P.E. |
|
2000 |
32 |
S1 |
p. A35- 1 p. |
artikel |
169 |
The effects of prednisone and budesonide on the activity and expression of the Na+ glucose co-transporter in trinitrobenzene sulfonic acid induced ileitis in the rat
|
Wild, G.E. |
|
2000 |
32 |
S1 |
p. A25- 1 p. |
artikel |
170 |
The natural history of fistulizing Crohn's disease: A population-based study
|
Schwartz, D.A. |
|
2000 |
32 |
S1 |
p. A18- 1 p. |
artikel |
171 |
The perception of quality of life in inflammatory bowel disease (IBD) mainly depends on disease activity
|
Saibeni, S. |
|
2000 |
32 |
S1 |
p. A33- 1 p. |
artikel |
172 |
The risk for dysplasia and neoplasia in the ileal pouch — A controversial issue
|
Hultén, Leif |
|
2000 |
32 |
S1 |
p. A31- 1 p. |
artikel |
173 |
The role of follow-up in the management of inflammatory bowel disease
|
Jakab, Zs. |
|
2000 |
32 |
S1 |
p. A20- 1 p. |
artikel |
174 |
The role of nicotine in IBD: The severity of experimental colitis in mice is dependent on the presence of the α5 neuronal nicotinic acetylcholine receptor subunit (nAChR)
|
Rachmilewitz, D. |
|
2000 |
32 |
S1 |
p. A31- 1 p. |
artikel |
175 |
The T cell substance P receptor is subject to immunoregulation
|
Blum, A. |
|
2000 |
32 |
S1 |
p. A26- 1 p. |
artikel |
176 |
The terminal ileum of the rat is responsive to betacellulin administration
|
Howarth, G.S. |
|
2000 |
32 |
S1 |
p. A30- 1 p. |
artikel |
177 |
The tissue embrionic antigens depending on the form of ulcerative colitis
|
Nikitina, N.V. |
|
2000 |
32 |
S1 |
p. A47- 1 p. |
artikel |
178 |
The TNFα-308∗2 allele predicts non-response to remicade®
|
Vermeire, S. |
|
2000 |
32 |
S1 |
p. A28- 1 p. |
artikel |
179 |
The use of alternative medicine practices amongst patients with inflammatory bowel disease
|
Chutkan, R. |
|
2000 |
32 |
S1 |
p. A48- 1 p. |
artikel |
180 |
The use of azathioprine in a severe case of steroid dependent ulcerative colitis
|
Abazi, A. |
|
2000 |
32 |
S1 |
p. A50- 1 p. |
artikel |
181 |
The use of magnetic resonance imaging and transabdominal bowel sonography in detecting fistulas in Crohn's disease
|
Djuranovic, S. |
|
2000 |
32 |
S1 |
p. A46- 1 p. |
artikel |
182 |
Transabdominal ultrasonography in inflammatory bowel diseases and its complications
|
Grbovic, A. |
|
2000 |
32 |
S1 |
p. A48- 1 p. |
artikel |
183 |
Treatment of fistulas in Crohn's disease with infliximab anti-tumor necrosis factor antibodies
|
Kohn, A. |
|
2000 |
32 |
S1 |
p. A8- 1 p. |
artikel |
184 |
Treatment options and surgical outcome for patients with dysplasia on ulcerative colitis
|
Laureti, S. |
|
2000 |
32 |
S1 |
p. A38- 1 p. |
artikel |
185 |
T-regulatory-1 cells prevent colitis induced by enteric bacterial antigen-reactive pathogenic Th1 cells
|
Cong, Y. |
|
2000 |
32 |
S1 |
p. A15- 1 p. |
artikel |
186 |
Trichuris suis appears safe and effective in treating inflammatory bowel disease, probably by modifying mucosal TH1/TH2 immune balance
|
Summers, R.W. |
|
2000 |
32 |
S1 |
p. A26- 1 p. |
artikel |
187 |
Tr1-like regulatory clones isolated from the lamina propria of DO11.10 transgenic mice inhibit Th1 cells proliferation and ameliorate CD45RBhigh colitis
|
Saparov, Arman |
|
2000 |
32 |
S1 |
p. A49- 1 p. |
artikel |
188 |
Tumour necrosis factor haplotype as a risk factor for low bone mass in ulcerative colitis
|
Nemetz, A. |
|
2000 |
32 |
S1 |
p. A32- 1 p. |
artikel |
189 |
Two and four mg/kg/day of IV cyclosporine are equally effective in severe attacks of ulcerative colitis
|
D'Haens, G. |
|
2000 |
32 |
S1 |
p. A18- 1 p. |
artikel |
190 |
Ulcerative colitis (UC) and Crohn's disease (CD) tissue gene expression profiling by DNA microarray techniques: Diagnostic and therapeutic implications
|
Lawrance, I.C. |
|
2000 |
32 |
S1 |
p. A30- 1 p. |
artikel |
191 |
Untoward effect of anti-TNF therapy in Crohn's disease — A case report
|
Annese, V. |
|
2000 |
32 |
S1 |
p. A6- 1 p. |
artikel |
192 |
Utilization and charges for pediatric inflammatory bowel disease (IBD)
|
Ferry, G. |
|
2000 |
32 |
S1 |
p. A26- 1 p. |
artikel |
193 |
What is the role of glutamine supported AIO parenteral nutrition in surgical severly depleted patients with IBD
|
Skowroñska-Piekarska, U. |
|
2000 |
32 |
S1 |
p. A17- 1 p. |
artikel |